Skip to main content
SpringerLink
Log in

Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview

  • Conference paper
Parkinson’s Disease and Related Disorders

Part of the book series: Journal of Neural Transmission. Supplementa ((NEURALTRANS,volume 70))

Summary

Sleep disturbances are frequent in Parkinson disease. These disorders can be broadly categorized into those that involve nocturnal sleep and excessive daytime sleepiness. The disorders that are often observed during the night in PD include sleep fragmentation that may be due to recurrent PD symptoms, sleep apnea, Restless Leg Syndrome/periodic limb movements and REM sleep behavior disorder. Excessive daytime sleepiness is also a common occurrence in PD. EDS can arise from several etiologies, and patients may have more than one etiology responsible. The causes of EDS include nocturnal sleep disorder with sleep deprivation and resulting daytime somnolence, the effect of drugs used to treat PD, and possibly neurodegeneration of central sleep/wake areas. Appropriate diagnosis of the sleep disturbance affecting a PD patient can lead to specific treatments that can consolidate nocturnal sleep and enhance daytime alertness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adler CH, Caviness JN, et al. (2003) Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson’s disease. Mov Disord 18(3): 287–293

    Article  PubMed  Google Scholar 

  • Albin RL, Koeppe RA, et al. (2000) Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 55(9): 1410–1412

    PubMed  CAS  Google Scholar 

  • Arnulf I, Bonnet AM, et al. (2000) Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis. Neurology 55(2): 281–288

    PubMed  CAS  Google Scholar 

  • Arnulf I, Konofal E, et al. (2002) Parkinson’s disease and sleepiness: an integral part of PD. Neurology 58(7): 1019–1024

    PubMed  CAS  Google Scholar 

  • Askenasy JJ, Weitzman ED, et al. (1987) Are periodic movements in sleep a basal ganglia dysfunction? J Neural Transm 70(3–4): 337–347

    Article  PubMed  CAS  Google Scholar 

  • Askenasy JJ, Yahr MD (1985) Reversal of sleep disturbance in Parkinson’s disease by antiparkinsonian therapy: a preliminary study. Neurology 35(4): 527–532

    PubMed  CAS  Google Scholar 

  • Baumann C, Ferini-Strambi L, et al. (2005) Parkinsonism with excessive daytime sleepiness — a narcolepsy-like disorder?” J Neurol 252(2): 139–145

    Article  PubMed  Google Scholar 

  • Boeve BF, Silber MH, et al. (2003) Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 4(4): 281–284

    Article  PubMed  Google Scholar 

  • Boeve BF, Silber MH, et al. (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16(4): 622–630

    Article  PubMed  CAS  Google Scholar 

  • Boeve BF, Silber MH, et al. (2003) Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 61(1): 40–45

    PubMed  CAS  Google Scholar 

  • Braga-Neto P, da Silva FP Jr, et al. (2004) Snoring and excessive daytime sleepiness in Parkinson’s disease. J Neurol Sci 217(1): 41–45

    Article  PubMed  Google Scholar 

  • Chiu HF, Wing YK, et al. (2000) Sleep-related injury in the elderly — an epidemiological study in Hong Kong. Sleep 23(4): 513–517

    PubMed  CAS  Google Scholar 

  • Comella CL (2003) Sleep disturbances in Parkinson’s disease. Curr Neurol Neurosci Rep 3(2): 173–180

    PubMed  Google Scholar 

  • Comella CL, Morrissey M, et al. (2005) Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology 64(8): 1450–1451

    PubMed  Google Scholar 

  • Comella CL, Nardine TM, et al. (1998) Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology 51(2): 526–529

    PubMed  CAS  Google Scholar 

  • Comella CL, Tanner CM, et al. (1993) Polysomnographic sleep measures in Parkinson’s disease patients with treatment-induced hallucinations. Ann Neurol 34(5): 710–714

    Article  PubMed  CAS  Google Scholar 

  • Drouot X, Moutereau S, et al. (2003) Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 61(4): 540–543

    PubMed  CAS  Google Scholar 

  • Dyken ME, Lin-Dyken DC, et al. (1995) Violent sleep-related behavior leading to subdural hemorrhage. Arch Neurol 52(3): 318–321

    PubMed  CAS  Google Scholar 

  • Eisensehr I, Linke R, et al. (2003) Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson’s disease, and controls. Sleep 26(5): 507–512

    PubMed  Google Scholar 

  • Eisensehr I, Lindeiner Hv, et al. (2001) REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson’s disease: is there a need for polysomnography? J Neurol Sci 186(1–2): 7–11

    Article  PubMed  CAS  Google Scholar 

  • Factor SA, Feustel PJ, et al. (2003) Longitudinal outcome of Parkinson’s disease patients with psychosis. Neurology 60(11): 1756–1761

    PubMed  CAS  Google Scholar 

  • Factor SA, McAlarney T, et al. (1990) Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord 5(4): 280–285

    Article  PubMed  CAS  Google Scholar 

  • Fantini ML, Gagnon JF, et al. (2003) The effects of pramipexole in REM sleep behavior disorder. Neurology 61(10): 1418–1420

    PubMed  CAS  Google Scholar 

  • Fenelon G, Mahieux F, et al. (2000) Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain 123 (Pt 4): 733–745

    Article  PubMed  Google Scholar 

  • Ferini-Strambi L (2002) Restless legs syndrome augmentation and pramipexole treatment. Sleep Med 3[Suppl]: S23–S25

    Article  PubMed  Google Scholar 

  • Ferini-Strambi L, Franceschi M, et al. (1992) Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 38(1–2): 92–98

    Article  PubMed  CAS  Google Scholar 

  • Fernandez HH, Friedman JH, et al. (1999) Quetiapine for the treatment of drug-induced psychosis in Parkinson’s disease. Mov Disord 14(3): 484–487

    Article  PubMed  CAS  Google Scholar 

  • Friedman JH, Fernandez HH (2002) Atypical antipsychotics in Parkinson-sensitive populations. J Geriatr Psychiatry Neurol 15(3): 156–170

    PubMed  Google Scholar 

  • Frucht S, Rogers JD, et al. (1999) Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52(9): 1908–1910

    PubMed  CAS  Google Scholar 

  • Frucht SJ, Greene PE, et al. (2000) Sleep episodes in Parkinson’s disease: a wake-up call. Mov Disord 15(4): 601–603

    Article  PubMed  CAS  Google Scholar 

  • Gagnon JF, Bedard MA, et al. (2002) REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 59(4): 585–589

    PubMed  CAS  Google Scholar 

  • Garcia-Borreguero D, Odin P, et al. (2003) Restless legs syndrome and PD: a review of the evidence for a possible association. Neurology 61[6 Suppl 3]: S49–S55

    PubMed  Google Scholar 

  • Gilman S, Koeppe RA, et al. (2003) REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology 61(1): 29–34

    PubMed  CAS  Google Scholar 

  • Gjerstad MD, Aarsland D, et al. (2002) Development of daytime somnolence over time in Parkinson’s disease. Neurology 58(10): 1544–1546

    PubMed  CAS  Google Scholar 

  • Happe S, Pirker W, et al. (2003) Periodic leg movements in patients with Parkinson’s disease are associated with reduced striatal dopamine transporter binding. J Neurol 250(1): 83–86

    Article  PubMed  Google Scholar 

  • Happe S, Schrodl B, et al. (2001) Sleep disorders and depression in patients with Parkinson’s disease. Acta Neurol Scand 104(5): 275–280

    Article  PubMed  CAS  Google Scholar 

  • Happe S, Trenkwalder C (2003) Movement disorders in sleep: Parkinson’s disease and restless legs syndrome. Biomed Tech (Berl) 48(3): 62–67

    Article  CAS  Google Scholar 

  • Hauser RA, Gauger L, et al. (2000) Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 15(4): 658–663

    Article  PubMed  CAS  Google Scholar 

  • Hirsch EC, Graybiel AM, et al. (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 84(16): 5976–5980

    Article  PubMed  CAS  Google Scholar 

  • Hobson DE, Lang AE, et al. (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. Jama 287(4): 455–463

    Article  PubMed  Google Scholar 

  • Hogl B, Rothdach A, et al. (2003) The effect of cabergo-line on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson’s disease. Neuropsychopharmacology 28(10): 1866–1870

    Article  PubMed  CAS  Google Scholar 

  • Hogl B, Saletu M, et al. (2002) Modafinil for the treatment of daytime sleepiness in Parkinson’s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 25(8): 905–909

    PubMed  CAS  Google Scholar 

  • Hogl B, Seppi K, et al. (2003) Increased daytime sleepiness in Parkinson’s disease: a questionnaire survey. Mov Disord 18(3): 319–323

    Article  PubMed  Google Scholar 

  • Homann CN, Suppan K, et al. (2003) Driving in Parkinson’s disease — a health hazard?” J Neurol 250(12): 1439–1446

    Article  PubMed  CAS  Google Scholar 

  • Iranzo A, Santamaria J (2005) Severe obstructive sleep apnea mimicking REM sleep behavior disorder. Sleep 28(2): 203–206

    PubMed  Google Scholar 

  • Iranzo A, Valldeoriola F, et al. (2002) Sleep symptoms and polysomnographic architecture in advanced Parkinson’s disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 72(5): 661–664

    Article  PubMed  CAS  Google Scholar 

  • Jansen EN, Meerwaldtt JD (1990) Madopar HBS in nocturnal symptoms of Parkinson’s disease. Adv Neurol 53: 527–531

    PubMed  CAS  Google Scholar 

  • Juncos JL, Fabbrini G, et al. (1987) Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations. Arch Neurol 44(10): 1010–1012

    PubMed  CAS  Google Scholar 

  • Kales A, Ansel RD, et al. (1971) Sleep in patients with Parkinson’s disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 12(2): 397–406

    PubMed  CAS  Google Scholar 

  • Lai YY, Siegel JM (2003) Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder. Mol Neurobiol 27(2): 137–152

    Article  PubMed  CAS  Google Scholar 

  • Larsen JP (2003) Sleep disorders in Parkinson’s disease. Adv Neurol 91: 329–334

    PubMed  Google Scholar 

  • Lees AJ (1987) A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson’s disease. Eur Neurol 27[Suppl 1]: 126–134

    PubMed  Google Scholar 

  • Lees AJ, Blackburn NA, et al. (1988) The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 11(6): 512–519

    Article  PubMed  CAS  Google Scholar 

  • Lesser RP, Fahn S, et al. (1979) Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 29(9 Pt 1): 1253–1260

    PubMed  CAS  Google Scholar 

  • Manni R, Pacchetti C, et al. (2002) Hallucinations and sleep-wake cycle in PD: a 24-hour continuous polysomnographic study. Neurology 59(12): 1979–1981

    PubMed  CAS  Google Scholar 

  • Maria B, Sophia S, et al. (2003) Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med 97(10): 1151–1157

    Article  PubMed  Google Scholar 

  • Mouret J (1975) Differences in sleep in patients with Parkinson’s disease. Electroencephalogr Clin Neurophysiol 38(6): 653–657

    Article  PubMed  CAS  Google Scholar 

  • Olson EJ, Boeve BF, et al. (2000) Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 123 (Pt 2): 331–339

    Article  PubMed  Google Scholar 

  • Ondo WG, Vuong KD, et al. (2002) Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59(3): 421–424

    Article  PubMed  Google Scholar 

  • Overeem S, van Hilten JJ, et al. (2002) Normal hypocretin-1 levels in Parkinson’s disease patients with excessive daytime sleepiness. Neurology 58(3): 498–499

    PubMed  CAS  Google Scholar 

  • Pahwa R, Busenbark K, et al. (1993) Clinical experience with controlled-release carbidopa/levodopa in Parkinson’s disease. Neurology 43(4): 677–681

    PubMed  CAS  Google Scholar 

  • Pal PK, Thennarasu K, et al. (2004) Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson’s disease and in their caregivers. Parkinsonism Relat Disord 10(3): 157–168

    Article  PubMed  CAS  Google Scholar 

  • Pappert EJ, Goetz CG, et al. (1999) Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson’s disease. Mov Disord 14(1): 117–121

    Article  PubMed  CAS  Google Scholar 

  • Priano L, Albani G, et al. (2003) Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. Neurol Sci 24(3): 207–208

    Article  PubMed  CAS  Google Scholar 

  • Razmy A, Lang AE, et al. (2004) Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 61(1): 97–102

    Article  PubMed  Google Scholar 

  • Ringman JM, Simmons JH (2000) Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 55(6): 870–871

    PubMed  CAS  Google Scholar 

  • Roth T, Rye DB, et al. (2003) Assessment of sleepiness and unintended sleep in Parkinson’s disease patients taking dopamine agonists. Sleep Med 4(4): 275–280

    Article  PubMed  Google Scholar 

  • Rye DB, Bliwise DL, et al. (2000) FAST TRACK: daytime sleepiness in Parkinson’s disease. J Sleep Res 9(1): 63–69

    Article  PubMed  CAS  Google Scholar 

  • Schapira AH (2004) Restless legs syndrome: an update on treatment options. Drugs 64(2): 149–158

    Article  PubMed  CAS  Google Scholar 

  • Schenck CH, Bundlie SR, et al. (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9(2): 293–308

    PubMed  CAS  Google Scholar 

  • Schenck CH, Bundlie SR, et al. (2002) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. 1986 [classical article]. Sleep 25(2): 293–308

    PubMed  Google Scholar 

  • Schenck CH, Bundlie SR, et al. (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46(2): 388–393

    PubMed  CAS  Google Scholar 

  • Schenck CH, Bundlie SR, et al. (1987) Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. Jama 257(13): 1786–1789

    Article  PubMed  CAS  Google Scholar 

  • Schenck CH, Mahowald MW (1991) Injurious sleep behavior disorders (parasomnias) affecting patients on intensive care units. Intensive Care Med 17(4): 219–224

    Article  PubMed  CAS  Google Scholar 

  • Silber MH, Shepard JW Jr, et al. (1997) Pergolide in the management of restless legs syndrome: an extended study. Sleep 20(10): 878–882

    PubMed  CAS  Google Scholar 

  • Stern M, Roffwarg H, et al. (1968) The parkinsonian tremor in sleep. J Nerv Ment Dis 147(2): 202–210

    Article  PubMed  CAS  Google Scholar 

  • Stevens S, Cormella CL et al. (2004) Daytime sleepiness and alertness in patients with Parkinson disease. Sleep 27(5): 967–972

    PubMed  Google Scholar 

  • Tan EK, Lum SY, et al. (2002) Evaluation of somnolence in Parkinson’s disease: comparison with age-and sex-matched controls. Neurology 58(3): 465–468

    PubMed  CAS  Google Scholar 

  • Tandberg E, Larsen JP, et al. (1998) A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 13(6): 895–899

    Article  PubMed  CAS  Google Scholar 

  • Tandberg E, Larsen JP, et al. (1999) Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov Disord 14(6): 922–927

    Article  PubMed  CAS  Google Scholar 

  • van Hilten B, Hoff JI, et al. (1994) Sleep disruption in Parkinson’s disease. Assessment by continuous activity monitoring. Arch Neurol 51(9): 922–928

    PubMed  Google Scholar 

  • Wetter TC, Collado-Seidel V, et al. (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep 23(3): 361–367

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurological Sciences, Rush University Medical Center, 1725 West Harrison, Suite 755, Chicago, IL, 60612, USA

    Prof. C. L. Comella MD

Authors
  1. Prof. C. L. Comella MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik fĂĽr Psychiatrie und Psychotherapie, WĂĽrzburg, Germany

    P. Riederer  & M. Gerlach  & 

  2. Universitätsklinikum der TU Dresden, Dresden, Germany

    H. Reichmann

  3. Israel Institute of Technology, Haifa, Israel

    M. B. H. Youdim

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag

About this paper

Cite this paper

Comella, C.L. (2006). Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview. In: Riederer, P., Reichmann, H., Youdim, M.B.H., Gerlach, M. (eds) Parkinson’s Disease and Related Disorders. Journal of Neural Transmission. Supplementa, vol 70. Springer, Vienna . https://doi.org/10.1007/978-3-211-45295-0_53

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-45295-0_53

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-28927-3

  • Online ISBN: 978-3-211-45295-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation